Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/13/13 → 3/31/15 |
Funding
- Savara Incorporated: $6,598.00
A phase 2, randomized, double blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients (SAV005-02)
- Danov, Zoran (PI)
- Anstead, Michael (CoI)
- Kanga, Jamshed (CoI)